Matching Clinical Studies
Showing results for "All Studies" | New search >>
A study evaluating the safety and efficacy of Debio 4326 in treating precocious puberty in children receiving gonadotropin-releasing hormone agonist
A Study to Assess the Efficacy, Safety and Pharmacokinetics of Debio 4326 in Pediatric Participants Receiving Gonadotropin-Releasing Hormone Agonist Therapy for Central Precocious Puberty (LIBELULA)
More about this study...
Currently recruiting
A study of a new way to treat children and young adults with a brain tumor called NGGCT
For complete details, please visit the study on clinicaltrials.gov
More about this study...
Currently recruiting
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
ACNS1831: A Phase 3 Randomized Study of Selumetinib (IND # 77782) versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
More about this study...
Currently recruiting
A study of treatment for medulloblastoma using sodium thiosulfate to prevent hearing loss
ACNS2031: A Phase 3 Study of Sodium Thiosulfate for the Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy for Children with Medulloblastoma with Low-Risk Features
More about this study...
Currently recruiting
A Study to Assess Children with Hypochondroplasia
A Multicenter Multinational Observational Study of Children with Hypochondroplasia
More about this study...
Currently recruiting
A study to compare standard therapy to treat Hodgkin Lymphoma with the use of two drugs, Brentuximab Vedotin and Nivolumab
AHOD2131: A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
More about this study...
Currently recruiting
A study to compare treatment with Selumetinib alone vs. Selumetinib and Vinblastine in patients with recurrent or progressive low-grade glioma
A Study to Compare Treatment with Selumetinib alone vs. Selumetinib and Vinblastine in patients with recurrent or progressive low-grade glioma
More about this study...
Currently recruiting
A study to give treatment inside the eye to treat retinoblastoma
ARET2121: Intravitreal Melphalan for Intraocular Retinoblastoma
More about this study...
Currently recruiting
A study to test the addition of the drug Cabozantinib to chemotherapy in patients with newly diagnosed osteosarcoma
AOST2032: A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
More about this study...
Currently recruiting
A study using risk factors to determine treatment for children with favorable histology Wilms tumors (FHWT)
AREN2231: Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT)
More about this study...
Currently recruiting
Accelerated v’s standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours (P3BEP)
AGCT1532 - P3BEP Trial, Phase 3 Accelerated BEP Trial: A randomized phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumors.
More about this study...
Currently recruiting
Active surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in treating pediatric and adult patients with germ cell tumors
AGCT1531, A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
More about this study...
Currently recruiting
Alpers Huttenlocher natural history study (Alpers)
Alpers Huttenlocher Natural History Study (Alpers)
More about this study...
Currently recruiting
An assessment of clinical efficacy of hypothermic therapy following Pivotal Trial II (mTBI) in the adolescent athlete with concussion
An assessment of clinical efficacy of hypothermic therapy following Pivotal Trial II (mTBI) in the adolescent athlete as compared to an untreated active control population
More about this study...
Currently recruiting
Biomarkers in tumor samples from patients with newly-diagnosed neuroblastoma or ganglioneuroblastoma
ANBL00B1 Neuroblastoma Biology Studies
More about this study...
Currently recruiting
Bracing vs casting in the treatment of idiopathic early-onset scoliosis
Bracing vs Casting in the Treatment of Idiopathic Early-Onset Scoliosis
More about this study...
Currently recruiting
Chemotherapy for the treatment of patients with newly-diagnosed very low risk and low risk fusion negative rhabdomyosarcoma
ARST2032: A Prospective Phase 3 Study of Patients with Newly Diagnosed Very Low-risk and Low-risk Fusion Negative Rhabdomyosarcoma
More about this study...
Currently recruiting
Dinutuximab with chemotherapy, surgery and stem cell transplantation for the treatment of children with newly-diagnosed high risk neuroblastoma
ANBL2131: A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma
More about this study...
Currently recruiting
Dupixent in post-burn pruritus
A Phase 2 Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy of Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic
More about this study...
Currently recruiting
Effects of Dexrazoxane Hydrochloride on biomarkers associated with cardiomyopathy and heart failure
ALTE11C2: Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
More about this study...
Currently recruiting
Efficacy of KL1333 in adult patients with primary mitochondrial disease
An interventional, randomised, double-blind, parallel-group, placebo-controlled, flexible-dose, adaptive study of the efficacy of KL1333 in adult patients with primary mitochondrial disease
More about this study...
Currently recruiting
Genetic Analysis Identifying Late Occurring Complications in Childhood Cancer Survivors (ALTE03N1)
ALTE03N1: Key Adverse Events After Childhood Cancer
More about this study...
Currently recruiting
Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
ANBL1232: Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-risk Neuroblastoma
More about this study...
Currently recruiting
IBD ImproveCareNow Registry - working to improve the care and health of children with inflammatory bowel disease
Using patient data to transform care and improve outcomes for children, adolescents, and young adults with Inflammatory Bowel Disease --- ImproveCareNow Database
More about this study...
Currently recruiting
Implementation of a US/Canadian Diagnostic Registry of Children with Chronic Vasculitis
ARCHIVE (A Registry for Children with Vasculitis: e-entry) Implementation of a US/Canadian Diagnostic Registry of Children with Chronic Vasculitis
More about this study...
Currently recruiting
Maintenance Chemotherapy or Observation Following Induction Chemo and Radiation for Ependymoma
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
More about this study...
Currently recruiting
Medical device study for patients with a rare kidney disease (Focal Segmental Glomerulosclerosis)
Treatment of Drug-Resistant Pediatric Focal Segmental Glomerulosclerosis Using the Liposorber ® LA-15 System
More about this study...
Currently recruiting
Nivolumab in combination with chemo-immunotherapy for the treatment of newly diagnosed primary mediastinal B-Cell lymphoma
ANHL1931: A Randomized Phase 3 trial of Nivolumab(NSC# 748726 IND# 125462) in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphoma
More about this study...
Currently recruiting
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
More about this study...
Currently recruiting
Currently recruiting
Prospective Database Registry of Scheuermann's Kyphosis
Prospective Database Registry of Scheuermann's Kyphosis
More about this study...
Currently recruiting
Prospective Database Registry of Scoliosis in Children with Cerebral Palsy
Prospective Database Registry Study of Scoliosis in Children with Cerebral Palsy
More about this study...
Currently recruiting
Recovery after ECMO in children with Acute Respiratory Distress Syndrome
ASCEND (ARDS in Children and ECMO initiation strategies impact on Neuro-Development)
More about this study...
Currently recruiting
ROCK Prospective Cohort Study for Osteochondritis Dissecans of the Knee
ROCK Comprehensive Prospective Cohort for Osteochondritis Dissecans of the Knee
More about this study...
Currently recruiting
Safety and efficacy of MACI in Patients with Chondral or Osteochondral Knee Defects (PEAK)
A prospective, open-label, randomized, concurrent active-controlled, longitudinal, multicenter, phase 3 clinical study of the safety and efficacy of MACI in patients aged 10 to 17 years with symptomatic chondral or osteochondral defects of the knee due to osteochondritis dissecans or acute trauma (PEAK Clinical Trial)
More about this study...
Currently recruiting
Safety and Efficacy of Nexium in Pediatric Patients with Erosive Esophagitis
A Phase III Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis in Pediatric Patients 1 to 11 Years of Age
More about this study...
Currently recruiting
Safety and efficacy of Ravulizumab for pediatric patients with thrombocytic microangiopathy following hematopoetic stem cell transplantation
ALXN1210-TMA-314: A Phase 3, Open-label, Single Arm, Multicenter Study of Ravulizumab in Addition to Best Supportive Care in Pediatric Participants (from 1 month to < 18 years of age) with Thrombotic Microangiopathy (TMA) after Hematopoietic Stem Cell Transplantation (HSCT)
More about this study...
Currently recruiting
Safety and efficacy of Rimegepant for the treatment of migraine in pediatric patients ≥6 to <18 years of age
Phase 3, multicenter, randomized, double-blind, group sequential, placebo-controlled study to assess efficacy and safety of rimegepant for the treatment of migraine (with or without aura) in children and adolescents ≥ 6 to <18 years of age
More about this study...
Currently recruiting
Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion
Subdermal Betadine to Reduce Microbacterial Bioburden During Posterior Spinal Fusion
More about this study...
Currently recruiting
Currently recruiting
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
A Phase 1 and Phase II and Re-Treatment Study of AZD6244 for Recurrent or Refractory Pediatric Low Grade Glioma
More about this study...
Currently recruiting
Selumetinib vs. Carboplatin and Vincristine in patients with low-grade glioma
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
More about this study...
Currently recruiting
STOP 360: Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes
Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes
More about this study...
Currently recruiting
Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
More about this study...
Currently recruiting
Study of Scoliosis Correction in patients with Marfan Syndrome
Study of Scoliosis Correction in Marfan Syndrome Patients
More about this study...
Currently recruiting
Study to determine the safety and tolerability of SNDX-5613 in patients with relapsed/refractory leukemia
AALL2121-A Phase 2 study of SNDX-5613 in combination with chemotherapy for patients with relapsed or refractory KMT2A-rearranged infant leukemia
More about this study...
Currently recruiting
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
ACCL1931: Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
More about this study...
Currently recruiting
The CARRA Registry for Pediatric Rheumatic Diseases
Observational Study Of Pediatric Rheumatic Diseases: The CARRA Registry
More about this study...
Currently recruiting
The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
APEC14B1 - The Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
More about this study...
Currently recruiting
Thoracotomy versus thoracoscopic management of pulmonary metastases in patients with osteosarcoma
AOST2031: A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma
More about this study...
Currently recruiting
Treatment of newly-diagnosed diffuse anaplastic Wilms tumors (SAWT) and relapsed favorable histology Wilms tumors (FHWT)
AREN1921: Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
More about this study...
No longer recruiting
TrialNet Pathway to Prevention of T1D
Pathway to Prevention Study Protocol TN-01
More about this study...

